CHEM-X-INFINITY partnered with XANCHEM to produce libraries around original scaffolds. The compounds will be of particular interest in the oncology field.

CHEM-X-INFINITY partnered with ORIBASE PHARMA to offer kinase focused libraries. The compounds are built around several small aza-heterocycles underused in combinatorial libraries and will have applications in the oncology field.

CHEM-X-INFINITY will attend the 18th Molecular Medicine Tri-Conference on February 23rd-25th, 2011 in San Francisco, CA.

The SCT Annual Workshop in Medicinal Chemistry was held the 7th of December in Paris at the Faculté de Médecine Cochin Port-Royal in collaboration with GFPP. Please read in this news our feeling about the event.

CHEM-X-INFINITY partnered with DIVERCHIM to design and produce original libraries from synthetic analogues of natural compounds. The compounds will be of particular interest in the oncology field.

CHEM-X-INFINITY attended the 21st International Symposium of Medicinal Chemistry on September 5th-9th, 2010, in Brussels, Belgium. Please read in this news our feeling about the event.

CHEM-X-INFINITY partnered with I-Stem Institute to identify new treatments for monogenic diseases. Chem-X-Infinity will supply compound libraries, library focusing and early hit-optimization.

CHEM-X-INFINITY is pleased to announce that it has received the accreditation for the French R&D tax credit for years 2009 to 2012. The system allows French companies to have a tax credit for R&D services outsourced in approved companies.

CHEM-X-INFINITY attended the 5th Drug Design and Lead Discovery Summit on October 14-16th, 2009, in San Diego, CA. The event covered new and common challenges faced during the research phase of the drug discovery process, as well as exciting and pertinent success stories. The conference had a focus on ligand-based drug design strategies that highlight the alternates, value, applicability, efficacy and effectiveness of pharmacophore-based strategies for lead finding and optimization.

CHEM-X-INFINITY is pleased to announce the signature of an agreement with the Structural Biology Laboratory of the Centro de Investigación Príncipe Felipe (CIPF) for the development of new original chemoinformatic models.